New thematic ETF targets the full peptide value chain: the drug developers, manufacturers, delivery specialists, and consumer brands behind today’s GLP-1 treatments and the pipeline forming beyond obesity, in one globally diversified trade. October 14, 2026 — REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX Peptide ETF (Ticker: … Continue reading REX Shares Launches REX Peptide ETF (PEPT)